Although some reports have suggested a link between the use of oral bisphosphonates (drugs that prevent the loss of bone mass) and esophageal cancer, analysis of medical data from more than 80,000 patients in the United Kingdom found that use of these drugs was not significantly associated with new cases of esophageal or gastric cancer, according to a study in the August 11 issue of JAMA. Bisphosphonates are mainly used to prevent or treat osteoporosis, especially in postmenopausal women… (Source: Health News from Medical News Today) Source: MedWorm: Oral Cancer
Tag: drugs
Use Of Certain Drugs To Treat Osteoporosis Not Associated With Increased Risk Of Esophageal Or Gastric Cancer
Tags: associated, Cancer, Certain, drugs, esophageal, Gastric, increased, Osteoporosis, risk, Treat
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
The phosphatidylinositide 3-kinase (PI3K) pathway is very commonly activated in a wide range of human cancers and is a major driving force in oncogenesis. One of the class I lipid kinase members of the PI3K family, p110, is probably the most commonly mutated kinase in the human genome. Alongside genetic, molecular biological, and biochemical studies, chemical inhibitors have been extremely helpful tools in understanding the role of PI3K enzymes in signal transduction and downstream physiological and pathological processes, and also in validating PI3Ks as therapeutic targets. Although they have been valuable in the past, the early and still frequently employed inhibitors, wortmannin and LY294002, have significant limitations as chemical tools. Here, we discuss the case history of the discov…
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.
Source: MedWorm: Oral Cancer
Poor And Inconsistent Reimbursement Of Oral Cancer Drugs Impairs Treatment
A comprehensive study of oral oncolytic (anti- cancer) drug treatments revealed that while their use is increasingly common, cancer patients frequently face barriers to accessing oral drugs compared to those delivered intravenously in oncology practice settings. (Source: Cancercompass News: Breast Cancer) Source: MedWorm: Oral Cancer
Tags: Cancer, drugs, Impairs, Inconsistent, Oral, Poor, Reimbursement, Treatment
Study: Poor And Inconsistent Reimbursement Of Oral Cancer Drugs Impairs Treatment
A comprehensive study of oral oncolytic (anti-cancer) drug treatments revealed that while their use is increasingly common, cancer patients frequently face barriers to accessing oral drugs compared to those delivered intravenously in oncology practice settings. Additionally, while oral anti-cancer drugs have advantages such as patient convenience, they require many crucial procedures by cancer treatment professionals — including management of side effects and monitoring for patient compliance but these key services are not reimbursed by Medicare or other payers… (Source: Health News from Medical News Today) Source: MedWorm: Oral Cancer
Tags: Cancer, drugs, Impairs, Inconsistent, Oral, Poor, Reimbursement, Study, Treatment
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).
Authors: Colomer R, Alba E, González-Martin A, Paz-Ares L, Martín M, Llombart A, Rodríguez Lescure A, Salvador J, Albanell J, Isla D, Lomas M, Rodríguez CA, Trigo JM, Germà JR, Bellmunt J, Tabernero J, Rosell R, Aranda E, Cubedo R, Baselga J,
PMID: 20110291 [PubMed - as supplied by publisher] (Source: Ann Oncol)
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.
Source: MedWorm: Oral Cancer
Tags: Cancer, drugs, Medical, Oncology, Oral, position, SEOM., Society, Spanish, statement, Treatment